Supplemental Condensed Consolidating Financial Information (Tables)

12 Months Ended

Dec. 31, 2011

Supplemental Financial Information [Abstract]

Condensed consolidating statement of income

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Net operating revenues	$	—		$	—		$	7,904,497		$	5,721,671		$	—		$	13,626,168
Operating costs and expenses:
Salaries and benefits		—			—			3,065,753			2,512,172			—			5,577,925
Provision for bad debts		—			—			1,003,252			716,704			—			1,719,956
Supplies		—			—			1,058,807			775,299			—			1,834,106
Other operating expenses		—			—			1,486,113			1,029,525			—			2,515,638
Electronic health records incentive reimbursement		—			—			(42,312	)		(21,085	)		—			(63,397	)
Rent		—			—			124,823			129,958			—			254,781
Depreciation and amortization		—			—			393,549			259,125			—			652,674
Total operating costs and expenses		—			—			7,089,985			5,401,698			—			12,491,683
Income from operations		—			—			814,512			319,973			—			1,134,485
Interest expense, net		—			87,095			495,258			62,057			—			644,410
Loss (gain) from early extinguishment of debt		—			66,019			—			—			—			66,019
Equity in earnings of unconsolidated affiliates		(201,948	)		(275,175	)		(101,101	)		—			528,733			(49,491	)
Income from continuing operations before income taxes		201,948			122,061			420,355			257,916			(528,733	)		473,547
Provision for (benefit from) income taxes		—			(79,887	)		151,748			65,792			—			137,653
Income from continuing operations		201,948			201,948			268,607			192,124			(528,733	)		335,894
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		—			—			—			(7,769	)		—			(7,769	)
Impairment of hospitals sold		—			—			—			(47,930	)		—			(47,930	)
Loss on sale, net		—			—			—			(2,572	)		—			(2,572	)
(Loss) income from discontinued operations, net of taxes		—			—			—			(58,271	)		—			(58,271	)
Net income		201,948			201,948			268,607			133,853			(528,733	)		277,623
Less: Net income attributable to noncontrolling interests		—			—			—			75,675			—			75,675
Net income attributable to Community Health Systems, Inc.	$	201,948		$	201,948		$	268,607		$	58,178		$	(528,733	)	$	201,948

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Net operating revenues	$	—		$	—		$	7,271,078		$	5,352,196		$	—		$	12,623,274
Operating costs and expenses:
Salaries and benefits		—			—			2,792,543			2,301,224			—			5,093,767
Provision for bad debts		—			—			901,580			629,272			—			1,530,852
Supplies		—			—			989,241			748,847			—			1,738,088
Other operating expenses		—			—			1,295,527			1,000,536			—			2,296,063
Electronic health records incentive reimbursement		—			—			—			—			—			—
Rent		—			—			118,215			130,248			—			248,463
Depreciation and amortization		—			—			348,037			246,960			—			594,997
Total operating costs and expenses		—			—			6,445,143			5,057,087			—			11,502,230
Income from operations		—			—			825,935			295,109			—			1,121,044
Interest expense, net		—			113,464			477,418			56,711			—			647,593
Loss (gain) from early extinguishment of debt		—			—			—			—			—			—
Equity in earnings of unconsolidated affiliates		(279,983	)		(312,730	)		(142,174	)		—			689,444			(45,443	)
Income from continuing operations before income taxes		279,983			199,266			490,691			238,398			(689,444	)		518,894
Provision for (benefit from) income taxes		—			(80,717	)		180,574			63,824			—			163,681
Income from continuing operations		279,983			279,983			310,117			174,574			(689,444	)		355,213
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		—			—			—			(6,772	)		—			(6,772	)
Impairment of hospitals sold		—			—			—			—			—			—
Loss on sale, net		—			—			—			—			—			—
(Loss) income from discontinued operations, net of taxes		—			—			—			(6,772	)		—			(6,772	)
Net income		279,983			279,983			310,117			167,802			(689,444	)		348,441
Less: Net income attributable to noncontrolling interests		—			—			—			68,458			—			68,458
Net income attributable to Community Health Systems, Inc.	$	279,983		$	279,983		$	310,117		$	99,344		$	(689,444	)	$	279,983

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Net operating revenues	$	—		$	—		$	6,763,647		$	4,978,807		$	—		$	11,742,454
Operating costs and expenses:
Salaries and benefits		—			—			2,630,349			2,070,882			—			4,701,231
Provision for bad debts		—			—			841,342			567,611			—			1,408,953
Supplies		—			—			933,730			716,049			—			1,649,779
Other operating expenses		—			—			1,169,896			959,185			—			2,129,081
Electronic health records incentive reimbursement		—			—			—			—			—			—
Rent		—			—			113,407			124,129			—			237,536
Depreciation and amortization		—			—			324,018			227,025			—			551,043
Total operating costs and expenses		—			—			6,012,742			4,664,881			—			10,677,623
Income from operations		—			—			750,905			313,926			—			1,064,831
Interest expense, net		—			110,507			479,458			53,643			—			643,608
Loss (gain) from early extinguishment of debt		—			(2,385	)		—			—			—			(2,385	)
Equity in earnings of unconsolidated affiliates		(243,150	)		(259,270	)		(157,491	)		—			623,380			(36,531	)
Impairment of long-lived and other assets		—			—			12,477			—			—			12,477
Income from continuing operations before income taxes		243,150			151,148			416,461			260,283			(623,380	)		447,662
Provision for (benefit from) income taxes		—			(92,002	)		159,921			73,932			—			141,851
Income from continuing operations		243,150			243,150			256,540			186,351			(623,380	)		305,811
Discontinued operations, net of taxes:
(Loss) income from operations of entities sold		—			—			(50	)		1,021			—			971
Impairment of hospitals sold		—			—			—			—			—			—
Loss on sale, net		—			—			—			(405	)		—			(405	)
(Loss) income from discontinued operations, net of taxes		—			—			(50	)		616			—			566
Net income		243,150			243,150			256,490			186,967			(623,380	)		306,377
Less: Net income attributable to noncontrolling interests		—			—			—			63,227			—			63,227
Net income attributable to Community Health Systems, Inc.	$	243,150		$	243,150		$	256,490		$	123,740		$	(623,380	)	$	243,150

Condensed Consolidating Balance Sheet

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	14,536		$	115,329	$	—		$	129,865
Patient accounts receivable, net of allowance for doubtful accounts		—			—			1,088,121			746,046		—			1,834,167
Supplies		—			—			215,203			131,408		—			346,611
Deferred income taxes		89,797			—			—			—		—			89,797
Prepaid expenses and taxes		101,389			117			83,983			28,513		—			214,002
Other current assets		—			10,235			141,192			80,220		—			231,647
Total current assets		191,186			10,352			1,543,035			1,101,516		—			2,846,089
Intercompany receivable		1,160,785			9,294,295			1,741,928			1,672,003		(13,869,011	)		—
Property and equipment, net		—			—			4,395,498			2,460,478		—			6,855,976
Goodwill		—			—			2,412,517			1,852,328		—			4,264,845
Other assets, net of accumulated amortization		—			99,521			523,645			618,764		—			1,241,930
Net investment in subsidiaries		1,758,458			6,413,757			2,450,625			—		(10,622,840	)		—
Total assets	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,954		$	9,625		$	4,127	$	—		$	63,706
Accounts payable		—			345			511,145			237,507		—			748,997
Deferred income taxes		—			—			—			—		—			—
Accrued interest		—			109,984			131			6		—			110,121
Accrued liabilities		7,580			567			662,746			317,422		—			988,315
Total current liabilities		7,580			160,850			1,183,647			559,062		—			1,911,139
Long-term debt		—			8,707,805			49,184			25,809		—			8,782,798
Intercompany payable		—			4,936,587			9,290,461			6,229,469		(20,456,517	)		—
Deferred income taxes		704,725			—			—			—		—			704,725
Other long-term liabilities		1,028			254,228			433,119			261,615		—			949,990
Total liabilities		713,333			14,059,470			10,956,411			7,075,955		(20,456,517	)		12,348,652
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			395,743		—			395,743
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		915			—			1			2		(3	)		915
Additional paid-in capital		1,086,008			701,399			769,841			59,941		(1,531,181	)		1,086,008
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(184,479	)		(184,479	)		(21,687	)		—		206,166			(184,479	)
Retained earnings		1,501,330			1,241,535			1,362,682			106,099		(2,710,316	)		1,501,330
Total Community Health Systems, Inc. stockholders’ equity		2,397,096			1,758,455			2,110,837			166,042		(4,035,334	)		2,397,096
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			67,349		—			67,349
Total equity		2,397,096			1,758,455			2,110,837			233,391		(4,035,334	)		2,464,445
Total liabilities and equity	$	3,110,429		$	15,817,925		$	13,067,248		$	7,705,089	$	(24,491,851	)	$	15,208,840

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	213,117		$	86,052	$	—		$	299,169
Patient accounts receivable, net of allowance for doubtful accounts		—			—			969,928			744,614		—			1,714,542
Supplies		—			—			193,902			135,212		—			329,114
Deferred income taxes		115,819			—			—			—		—			115,819
Prepaid expenses and taxes		118,464			116			88,647			11,991		—			219,218
Other current assets		—			41			137,113			56,177		—			193,331
Total current assets		234,283			157			1,602,707			1,034,046		—			2,871,193
Intercompany receivable		1,079,294			9,002,158			1,424,734			1,370,494		(12,876,680	)		—
Property and equipment, net		—			—			3,889,651			2,434,786		—			6,324,437
Goodwill		—			—			2,331,452			1,818,795		—			4,150,247
Other assets, net of accumulated amortization		—			131,352			438,131			782,763		—			1,352,246
Net investment in subsidiaries		1,510,063			5,267,860			1,944,795			—		(8,722,718	)		—
Total assets	$	2,823,640		$	14,401,527		$	11,631,470		$	7,440,884	$	(21,599,398	)	$	14,698,123
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,953		$	11,070		$	2,116	$	—		$	63,139
Accounts payable		—			—			361,088			165,250		—			526,338
Deferred income taxes		8,882			—			—			—		—			8,882
Accrued interest		—			146,297			116			2		—			146,415
Accrued liabilities		7,595			567			567,101			322,003		—			897,266
Total current liabilities		16,477			196,817			939,375			489,371		—			1,642,040
Long-term debt		—			8,734,473			44,831			29,078		—			8,808,382
Intercompany payable		—			3,619,651			8,424,670			6,086,227		(18,130,548	)		—
Deferred income taxes		608,177			—			—			—		—			608,177
Other long-term liabilities		9,522			340,526			371,667			279,960		—			1,001,675
Total liabilities		634,176			12,891,467			9,780,543			6,884,636		(18,130,548	)		12,060,274
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			387,472		—			387,472
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		936			—			1			2		(3	)		936
Additional paid-in capital		1,126,751			640,683			685,921			39,693		(1,366,297	)		1,126,751
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(230,927	)		(230,927	)		(12,990	)		—		243,917			(230,927	)
Retained earnings		1,299,382			1,100,304			1,177,995			68,169		(2,346,468	)		1,299,382
Total Community Health Systems, Inc. stockholders’ equity		2,189,464			1,510,060			1,850,927			107,864		(3,468,851	)		2,189,464
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			60,913		—			60,913
Total equity		2,189,464			1,510,060			1,850,927			168,777		(3,468,851	)		2,250,377
Total liabilities and equity	$	2,823,640		$	14,401,527		$	11,631,470		$	7,440,885	$	(21,599,399	)	$	14,698,123

Condensed consolidating statement of cash flows

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(41,780	)	$	(111,011	)	$	840,582		$	574,117		$	—		$	1,261,908
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(370,243	)		(45,117	)		—			(415,360	)
Purchases of property and equipment		—			—			(440,754	)		(335,959	)		—			(776,713	)
Proceeds from disposition of hospitals and other ancillary operations		—			—			—			173,387			—			173,387
Proceeds from sale of property and equipment		—			—			2,283			8,877			—			11,160
Increase in other investments		—			(10,000	)		(129,852	)		(48,397	)		—			(188,249	)
Net cash used in investing activities		—			(10,000	)		(938,566	)		(247,209	)		—			(1,195,775	)
Cash flows from financing activities:
Proceeds from exercise of stock options		18,910			—			—			—			—			18,910
Repurchase of restricted stock shares for payroll tax withholding requirements		(13,311	)		—			—			—			—			(13,311	)
Deferred financing costs		—			(19,352	)		—			—			—			(19,352	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		5,290			—			—			—			—			5,290
Stock buy-back		(85,790	)		—			—			—			—			(85,790	)
Proceeds from noncontrolling investors in joint ventures		—			—			—			1,229			—			1,229
Redemption of noncontrolling investments in joint ventures		—			—			—			(13,022	)		—			(13,022	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(56,094	)		—			(56,094	)
Changes in intercompany balances with affiliates, net		116,681			209,066			(95,945	)		(229,802	)		—			—
Borrowings under credit agreement		—			560,000			18,236			2,145			(2,145	)		578,236
Issuance of long-term debt		—			1,000,000			—			—			—			1,000,000
Repayments of long-term indebtedness		—			(1,628,703	)		(22,888	)		(2,087	)		2,145			(1,651,533	)
Net cash provided by (used in) financing activities		41,780			121,011			(100,597	)		(297,631	)		—			(235,437	)
Net change in cash and cash equivalents		—			—			(198,581	)		29,277			—			(169,304	)
Cash and cash equivalents at beginning of period		—			—			213,117			86,052			—			299,169
Cash and cash equivalents at end of period	$	—		$	—		$	14,536		$	115,329		$	—		$	129,865

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations		Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(154,101	)	$	(87,018	)	$	782,993		$	646,856		$	—	$	1,188,730
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(204,773	)		(43,478	)		—		(248,251	)
Purchases of property and equipment		—			—			(342,735	)		(324,643	)		—		(667,378	)
Proceeds from disposition of hospitals and other ancillary operations		—			—			—			—			—		—
Proceeds from sale of property and equipment		—			—			8,140			261			—		8,401
Increase in other investments		—			—			(112,587	)		(24,495	)		—		(137,082	)
Net cash used in investing activities		—			—			(651,955	)		(392,355	)		—		(1,044,310	)
Cash flows from financing activities:
Proceeds from exercise of stock options		56,916			—			—			—			—		56,916
Repurchase of restricted stock shares for payroll tax withholding requirements		—			—			—			—			—		—
Deferred financing costs		—			(13,260	)		—			—			—		(13,260	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		10,219			—			—			—			—		10,219
Stock buy-back		(113,961	)		—			—			—			—		(113,961	)
Proceeds from noncontrolling investors in joint ventures		—			—			—			7,201			—		7,201
Redemption of noncontrolling investments in joint ventures		—			—			—			(7,318	)		—		(7,318	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(68,113	)		—		(68,113	)
Changes in intercompany balances with affiliates, net		200,927			144,788			(142,864	)		(202,851	)		—		—
Borrowings under credit agreement					—			—			—			—		—
Issuance of long-term debt		—			—			—			—			—		—
Repayments of long-term indebtedness		—			(44,510	)		(13,507	)		(3,459	)		—		(61,476	)
Net cash provided by (used in) financing activities		154,101			87,018			(156,371	)		(274,540	)		—		(189,792	)
Net change in cash and cash equivalents		—			—			(25,333	)		(20,039	)		—		(45,372	)
Cash and cash equivalents at beginning of period		—			—			238,450			106,091			—		344,541
Cash and cash equivalents at end of period	$	—		$	—		$	213,117		$	86,052		$	—	$	299,169

	Parent Guarantor			Issuer			Other Guarantors			Non- Guarantors			Eliminations			Consolidated
	(In thousands)
Net cash (used in) provided by operating activities	$	(62,883	)	$	(88,486	)	$	671,528		$	556,270		$	—		$	1,076,429
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(199,363	)		(64,410	)		—			(263,773	)
Purchases of property and equipment		—			—			(368,408	)		(208,480	)		—			(576,888	)
Proceeds from disposition of hospitals and other ancillary operations		—			—			—			89,514			—			89,514
Proceeds from sale of property and equipment		—			—			824			3,195			—			4,019
Increase in other investments		—			—			(115,799	)		(4,255	)		—			(120,054	)
Net cash used in investing activities		—			—			(682,746	)		(184,436	)		—			(867,182	)
Cash flows from financing activities:
Proceeds from exercise of stock options		12,759			—			—			—			—			12,759
Repurchase of restricted stock shares for payroll tax withholding requirements		—			—			—			—			—			—
Deferred financing costs		—			(82	)		—			—			—			(82	)
Excess tax benefit (income tax payable increase) relating to stock-based compensation		(3,472	)		—			—			—			—			(3,472	)
Stock buy-back		—			—			—			—			—			—
Proceeds from noncontrolling investors in joint ventures		—			—			—			29,838			—			29,838
Redemption of noncontrolling investments in joint ventures		—			—			—			(7,268	)		—			(7,268	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(58,963	)		—			(58,963	)
Changes in intercompany balances with affiliates, net		53,596			135,518			100,944			(290,058	)		—			—
Borrowings under credit agreement		—			200,000			4,045			2,570			(6,615	)		200,000
Issuance of long-term debt		—			—			—			—			—			—
Repayments of long-term indebtedness		—			(246,950	)		(13,853	)		(3,985	)		6,615			(258,173	)
Net cash provided by (used in) financing activities		62,883			88,486			91,136			(327,866	)		—			(85,361	)
Net change in cash and cash equivalents		—			—			79,918			43,968			—			123,886
Cash and cash equivalents at beginning of period		—			—			158,532			62,123			—			220,655
Cash and cash equivalents at end of period	$	—		$	—		$	238,450		$	106,091		$	—		$	344,541